A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer

J.S.W. Lind; A.M.C. Dingemans; H.J.M. Groen; F.B.J.M. Thunnissen; O. Bekers; D.A.M. Heideman; R.J. Honeywell; E. Giovannetti; G.J. Peters; P.E. Postmus; R.J. van Suylen; E.F. Smit

doi:https://doi.org/10.1158/1078-0432.CCR-09-3033

A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer

J.S.W. Lind, A.M.C. Dingemans, H.J.M. Groen, F.B.J.M. Thunnissen, O. Bekers, D.A.M. Heideman, R.J. Honeywell, E. Giovannetti, G.J. Peters, P.E. Postmus, R.J. van Suylen, E.F. Smit

Research output: Contribution to journal › Article › Academic › peer-review

80 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3078-3087
Journal	Clinical Cancer Research
Volume	16
Issue number	11
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-3033
Publication status	Published - 2010

Access to Document

https://doi.org/10.1158/1078-0432.CCR-09-3033

Cite this

Lind, J. S. W., Dingemans, A. M. C., Groen, H. J. M., Thunnissen, F. B. J. M., Bekers, O., Heideman, D. A. M., Honeywell, R. J., Giovannetti, E., Peters, G. J., Postmus, P. E., van Suylen, R. J., & Smit, E. F. (2010). A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research, 16(11), 3078-3087. https://doi.org/10.1158/1078-0432.CCR-09-3033

@article{e4cda0280a4446e78f1ec2e63d48bdb3,

title = "A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer",

author = "J.S.W. Lind and A.M.C. Dingemans and H.J.M. Groen and F.B.J.M. Thunnissen and O. Bekers and D.A.M. Heideman and R.J. Honeywell and E. Giovannetti and G.J. Peters and P.E. Postmus and {van Suylen}, R.J. and E.F. Smit",

year = "2010",

doi = "https://doi.org/10.1158/1078-0432.CCR-09-3033",

language = "Undefined/Unknown",

volume = "16",

pages = "3078--3087",

journal = "Clinical cancer research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "11",

}

Lind, JSW, Dingemans, AMC, Groen, HJM, Thunnissen, FBJM, Bekers, O, Heideman, DAM , Honeywell, RJ , Giovannetti, E , Peters, GJ, Postmus, PE, van Suylen, RJ & Smit, EF 2010, 'A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer', Clinical Cancer Research, vol. 16, no. 11, pp. 3078-3087. https://doi.org/10.1158/1078-0432.CCR-09-3033

TY - JOUR

T1 - A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naive Patients with Advanced Non-Small Cell Lung Cancer

AU - Lind, J.S.W.

AU - Dingemans, A.M.C.

AU - Groen, H.J.M.

AU - Thunnissen, F.B.J.M.

AU - Bekers, O.

AU - Heideman, D.A.M.

AU - Honeywell, R.J.

AU - Giovannetti, E.

AU - Peters, G.J.

AU - Postmus, P.E.

AU - van Suylen, R.J.

AU - Smit, E.F.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.1158/1078-0432.CCR-09-3033

DO - https://doi.org/10.1158/1078-0432.CCR-09-3033

M3 - Article

C2 - 20395213

SN - 1078-0432

VL - 16

SP - 3078

EP - 3087

JO - Clinical cancer research

JF - Clinical cancer research

IS - 11

ER -